Pentoxifylline, ciprofloxacin and dexamethasone improve the ineffective hematopoiesis in myelodysplastic syndrome patients

Hematology

Volumn 5, Issue 4, 2000, Pages 275-284

  Raza, A ^a   Qawi, H ^a   Andric, T ^a   Dar, S ^a   Lisak, L ^a   Huang, R W ^a   Venugopal, P ^a   Gezer, S ^a   Gregory, S A ^a   Hsu, W T ^a   Loew, J ^a   Robin, E ^a   Rifkin, S ^a   Shah, R ^a   Divgi, A ^a   Taylor, R ^a   Grosset, A ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

Hematopoiesis; Myelodysplastic syndrome

Indexed keywords

CIPROFLOXACIN; CYTOKINE; DEXAMETHASONE; GROWTH FACTOR; PENTOXIFYLLINE;

ANXIETY; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; BONE MARROW; CELL LINEAGE; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG RESPONSE; DYSPEPSIA; EUPHORIA; FATIGUE; FLUID RETENTION; HEARTBURN; HEMATOLOGY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; INDIGESTION; IRRITABILITY; MUSCLE WEAKNESS; MYELODYSPLASTIC SYNDROME; NAUSEA; NEUTROPHIL; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTORY ANEMIA; SIDE EFFECT; SKIN TINGLING; STOMATITIS; VERTIGO; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 0034468435     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245332.2000.11746517     Document Type: Article

References (20)

1. The nature and natural history of myelodysplasia
2. The myelodysplastic syndromes
3. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes
4. Incidence and role of apoptosis in myelodysplastic syndrome: Morphological and ultrastructural assessment
5. Morphologic changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocytes-CSF and erythropoietin
6. Indication of an involvement of interleukin-1β converting enzyme (ICE)-like protease in intramedullary apoptotic cell death in the bone marrows of patients with myelodysplastic syndromes (MDS)
7. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes
8. The myelodysplastic syndromes in 1996: Complex stem cell disorders confounded by dual actions of cytokines
9. A potential role for phosphatidic acid in mediating the inflammatory responses of TNF-? and IL-1
10. Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony stimulating factor in combination with erythropoietin
11. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndromes
12. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid
13. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/TNF-snthesis at separate points in the signalling pathway
14. Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome
15. Glucocorticoid therapy in the pre-leukemic syndrome (hematopoietic dysplasia). Identification of responsive patients using in-vitro techniques
16. Mechanism of glucocorticoid activity in patients with pre-leukemic syndrome (hemopoietic dysplasia)
17. Hematopoietic growth factors for the treatment of myelodysplastic syndromes
18. Subcutaneous GM-CSF in patients with myelodysplastic syndromes: Toxicity, pharmacokinetics and hematologic effects
19. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes